SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-15-001382
Filing Date
2015-04-30
Accepted
2015-04-30 07:04:20
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1516637.htm 20-F 3425259
2 EXHIBIT 4.4.2 exhibit_4-42.htm EX-4.4.2 46348
3 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 6717
4 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 13493
5 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 13485
6 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5188
7 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5300
8 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 4419
9 logo.jpg GRAPHIC 3299
10 ey2.jpg GRAPHIC 4435
  Complete submission text file 0001178913-15-001382.txt   3532122
Mailing Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121
Business Address 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100 REHOVOT L3 76121 97289311900
Evogene Ltd. (Filer) CIK: 0001574565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36187 | Film No.: 15815090
SIC: 2870 Agricultural Chemicals